Vimarsana
Biggest News Aggregation in the World

Jeffrey Rona News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jeffrey Rona. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jeffrey Rona Today - Breaking & Trending Today

S&W Seed plants biotech executive in board seat - Vimarsana News

S&W Seed plants biotech executive in board seat

S&W Seed Co. (Nasdaq: SANW) has tapped biotechnology executive Jeffrey Rona to serve on its board of directors.

S&W Seed Company Appoints Jeffrey Rona to Its Board of Directors - Vimarsana News

S&W Seed Company Appoints Jeffrey Rona to Its Board of Directors

LONGMONT, Colo., Dec. 19, 2023 /PRNewswire/ -- S&W Seed Company , a global agricultural technology company, today announced the nomination of senior biotechnology executive Jeffrey Rona to its Board...

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway into 2026 -October 18, 2023 at 08:03 am EDT - Vimarsana News

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway into 2026 -October 18, 2023 at 08:03 am EDT

Ligand will receive 13% of all soticlestat royalties and milestone payments owed to OvidOvid secures a $30 million non-dilutive capital infusion from Ligand, which Ovid expects to extend its cash...

Chutes & Ladders—FDA nod for Biogen's Aduhelm sees trio of AdComm members hit the exit - Vimarsana News

Chutes & Ladders—FDA nod for Biogen's Aduhelm sees trio of AdComm members hit the exit

Ogilvy and McCann heavyweight Andrew Schirmer has joined Syneos Health's GSW New York as president. Three members of the FDA panel that argued against aducanumab have quit in the wake of the Alzheimer's drug's approval. Inogen, recently equipped with a new CEO, has tapped BD vet Stanislav Glezer, M.D., as its chief medical officer.